administration followed by stem cell collection during the rebound recovery period. [3][4][5] However, the mechanism of PC mobilization is not well understood. Whether hematoTo determine the effect of growth factor mobilization on the expression of adhesion molecules, we compared poietic PCs circulate or remain within the BM may depend on the presence and function of adhesion molecules.
Summary:
administration followed by stem cell collection during the rebound recovery period. [3] [4] [5] However, the mechanism of PC mobilization is not well understood. Whether hematoTo determine the effect of growth factor mobilization on the expression of adhesion molecules, we compared poietic PCs circulate or remain within the BM may depend on the presence and function of adhesion molecules.
6-9
CD34
؉ progenitor cell (PC) populations from steadystate bone marrow (BM) with granulocyte-macrophage Adhesion molecules mediate the adhesion of hematopoietic stem cells to the marrow stromal and endothelial cells and colony-stimulating factor (GM-CSF)-mobilized apheresis products (peripheral blood stem cell (PSC) ) using play a pivotal role in PC mobilization and homing. 
10-13
Lewis X were observed on PSC as compared to BM CD34 + cells. Significantly higher levels of L-selectin and One strategy to gain insight into the mechanism of mobilization is to compare the expression of adhesion molecules CD44 expression were observed on PSC as compared to BM CD34 + cells based on frequency and MFI (P р on CD34 + cells. However, the results from such studies have been inconsistent. This variability has been due in part 0.05). In addition, the duration of GM-CSF administration or number of prior aphereses had no effect on to the low frequency of CD34 + cells in the stem cell population making analysis difficult. One consistent observation adhesion molecule expression. These data suggest that decreased expression of adhesion molecules including has been that VLA-4 has a critical role in the mobilization of PCs in response to G-CSF in primate studies. 6 Studies VLA-4, LFA-1, ICAM-1 and LFA-3 play a role in PC mobilization. Based on these studies, we suggest that PC in rodents have confirmed this observation and also shown that the counter-receptor is vascular cell adhesion moleculemobilization occurs as a stochastic process and is associated with the selection of CD34 + cells with low 1 (VCAM)- 15 To address the question of adhesion specimens were analyzed on the second collection day, five specimens were analyzed on the third collection day, molecule expression during mobilization of PSC, using an alternative growth factor in the absence of chemotherapy and five specimens were analyzed on the fourth or more collection days. Specimens were analyzed after red blood for mobilization (GM-CSF) we undertook a comparison of adhesion molecule expression on CD34
+ cells in steadycell lysis by ammonium chloride (Fisher Chemical, Fair Lawn, NJ, USA) buffer and/or separation on Ficollstate BM products with GM-CSF-mobilized CD34 + cells from leukapheresis products following CD34
+ cell enrichHypaque density gradient. The BM and PSC samples were obtained using protocols approved by the Institutional ment on a colloid bead cell isolation system (MiniMACS).
Review Board at UNMC.
Materials and methods

Enrichment of CD34
+ cells CD34 + cells were isolated from BM and leukapheresis proPatients' characteristics and stem cell harvest ducts using the colloid bead CD34 PC isolation kit The patients characteristics are listed in Table 1 . Written (MiniMACS; Miltenyi Biotec, Sunnyvale, CA, USA), informed consent for stem cell collection and autologous according to the instructions of the manufacturer. Monotransplantation was obtained from each patient. The PCs nuclear cells (2-5 × 10 8 ) were loaded on each isolation colexamined in this study were collected for transplantation umn, but were not isolated a second time. The antibody between August 1995 and April 1996 at the University of used was a modified CD34 antibody (QBEND/10, mouse Nebraska Medical Center. All patients had received mulIgG 1 ). tiple cycles of chemotherapy more than 90 days before harvesting. Ten patients in the PSC group had BM involveMonoclonal antibodies (MoAbs) ment at the time of harvesting, but none in the BM group. No BM fibrosis was observed in any of the patients by Two-or three-color fluorescence was performed by simulhistologic examination before PSC harvest. BM products taneous labeling with FITC, PE, and biotin (or cy-chrome)-were harvested from patients in steady-state hematopoiesis conjugated MoAbs at optimal (saturating) concentrations. by standard procedures. In a different set of patients, PSC Specificity, family, CD number, clone, conjugation, Ig subwere collected from patients who received 250 g/m 2 /day classes, and supplier of the monoclonal antibodies investi-GM-CSF (Sargramostim, Immunex, Seattle, WA, USA) gated in this study are listed in Table 2 . Labeled sialyl daily starting 4-5 days before collection and continued until Lewis X and sialyl Lewis A antibodies are not available comcompletion of the leukapheresis. No patient received mercially, and were therefore labeled with FITC using the chemotherapy for mobilization and in all instances the Quick tag FITC conjugation kit (Boehringer Mannheim, patients examined had not received chemotherapy or radioIndianapolis, IN, USA). therapy for the preceding 90 days. Leukaphereses were performed as an outpatient procedure with a continuous flow Flow cytometry analysis blood cell separator (COBE Spectra; COBE BCT, LakeTwo-or three-color experiments were used to investigate adhesion molecules on the CD34 + enriched fraction of BM respectively). In contrast, the frequency of L-selectin and CD44 expression were significantly higher on PSC than
Statistics analysis
Statistical analyses using a paired (for multiple analyses of apheresis sample, from the same patient) or unpaired t-test was performed using SPSS for Windows. Significance levels were set at 0.05.
Results
Enrichment of CD34 + cells
The percentages of CD34 + cells in samples from BM and PSC before CD34 + cell enrichment were determined and revealed that the CD34 + cell frequency was significantly higher in BM (P = 0.003) than PSC products (3.86 Ϯ 0.33% vs 0.95 Ϯ 0.16%; mean Ϯ s.e.m.). After enrichment of CD34 + cells, the purity of the CD34 + population ranged from 15 to 91% (mean 48%) for BM and 14 to 89% (mean 56%) for PSC (no significant difference). The recovery of CD34 + cells was 67 ± 15% for BM and 51 ± 18% for PSC products (no significant difference). 
BM CD34
+ cells. The PSC CD34 + cells also had a significantly greater MFI (Figure 3 ) of L-selectin and CD44 (P р 0.05). There were no significant differences in the frequency of ICAM-1, Mac-1 and CD38 expression on BM CD34
+ cells compared to PSC CD34 + cells. Furthermore, no differences were observed for the MFI of LFA-1, Mac-1, LFA-3, sialyl Lewis A , CD38 and Thy-1 between BM CD34 + cells and PSC CD34 + cells. For the PSC products, we also analyzed the effect of the timing of PSC collection on adhesion molecule expression. We found that there was no significant difference among the different collection days (the first day vs the second day vs the third day vs the fourth or more days (Figure 4) ). No. of collection Furthermore, we analyzed the effect of tumor involvement + BM fractions (data not shown). However, when the frequency of expression is lower (PSC products), significant differences were found (data not shown), suggesting that nonspecific binding cells were identified as positive. These results also demonstrated that the isolation with colloid beads did not affect adhesion molecule expression (based on the BM cell analysis) and that the selected CD34 + cells retained phenotypic characteristics similar to the unseparated cells.
Among the adhesion molecules analyzed, lower expression of VLA-4, LFA-1, and LFA-3 and higher expression of L-selectin and CD44 were found on GM-CSF-mobilized PSC CD34
+ cells as compared to BM CD34 + cells. The characteristics of the donors for the PSC and BM products were similar for the two cohorts except for BM involvement at the time of harvesting. However, no effect of BM involvement on adhesion molecule expression of PSC CD34
+ cells was observed. The different patterns of adhesion molecule expression suggests that a subset of CD34 + cells circulate in the peripheral blood, perhaps selected from a heterogeneous population in the BM. Alternately, a marginated pool of PCs, perhaps from the liver, are released into the circulation in response to growth factor administration. Such heterogeneity may also occur to facilitate the egress of PCs from the BM as suggested by recent studies demonstrating the effects of in vivo treatment with anti-VLA-4 antibody. 6,14 BM CD34 + cells may acquire the capacity to circulate by changing the pattern of Discussion adhesion molecule expression following GM-CSF administration. However, GM-CSF is known to upregulate specific This study was designed to evaluate differences in the expression of adhesion molecules on CD34 + cells in periphadhesion molecules including those in the integrin family on PCs, monocytes and endothelial cells, [23] [24] [25] although eral blood leukapheresis products (GM-CSF-mobilized) in comparison to CD34 + cells in steady-state BM products. there is one report that LFA-1 and ICAM-1 expression on CD34 + cells is decreased following 15-17 days of growth Since CD34 is nearly undetectable in steady-state blood cells, no valid comparison can be made with that popufactor (GM-CSF or G-CSF) administration. 26 PCs with a low level of VLA-4 and Ig superfamily expression might lation. Several studies have indicated that the CD34 + cell fraction comprises 1.8-5.4% of the total mononuclear cells selectively migrate from the BM through fenestration in the capillaries, which may be induced by GM-CSF, or because in the steady-state BM, and 0.15-1.5% of the cells in the apheresis product of mobilized peripheral blood. [18] [19] [20] [21] Thus, of crowding due to marrow hypercellularity after GM-CSF administration. Poor adhesive properties of CD34 + cells even in mobilized products the peripheral blood CD34 + cell concentration can approach the limits of flow cytometric with a low expression of integrin and Ig superfamily adhesion molecule may facilitate the selection of this subset detection. Furthermore, because the flow cytometric analysis of rare events is relatively inaccurate, the analysis of of CD34 + cells or retain these cells in the circulation. Alternatively, growth factor administration may result in adhesion molecule expression on such an infrequent cell population cannot be accurately determined. In the ideal changes to the BM environment that reduces stem cell adhesion. In contrast, CD34 + cells in the peripheral blood analysis, the frequency of nonspecific binding, which is determined with control antibodies of the same Ig isotypes, with a high level of VLA-4 expression might rapidly extravasate into the BM or other sites, and not remain in should be less than 0.1%. With the available technology and the frequency of CD34 + cells in intact products, the the circulation. In addition, this study showed no effect of the timing of the PSC collection on adhesion molecule nonspecific binding may be close to the frequency of specific binding, especially in PSC products. To solve these expression, which might support this hypothesis. In this study, a higher expression of L-selectin and CD44 problems, we enriched the CD34 + cells using a colloid bead separation method prior to adhesion molecule analysis. 22 was observed on GM-CSF-mobilized PSC CD34
+ cells as compared to BM CD34 + cells. Selectins play an important Our preliminary data showed that there were no significant the lymphocyte homing adhesion molecules. 28 Among the
